Marimed (MRMD) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
4 Jun, 2026Opening remarks and agenda
The meeting was called to order by the President and CEO, who welcomed attendees and outlined the virtual format and agenda, emphasizing inclusivity and the order of business followed by a Q&A session.
Legal counsel, independent auditor, and board members were introduced, and meeting roles were assigned.
Board and executive committee updates
Directors present included the Chairman of the Board and three other board members.
The re-election of four directors to serve until the 2027 annual meeting was proposed and recommended by the board.
Overview of voting outcomes
A quorum was confirmed with over 50% of eligible votes present.
All director nominees were re-elected, and the appointment of the independent auditor for 2026 was approved.
Final voting results will be filed with the SEC within four business days.
Latest events from Marimed
- Revenue up 4.2% to $39.5M, adjusted EBITDA improved, and liquidity enhanced by restructuring.MRMD
Q1 202614 May 2026 - 2025 revenue rose 7% to $159.8M, driven by 11% wholesale growth and improved liquidity.MRMD
Q4 202525 Apr 2026 - Shareholders will vote on director elections and auditor approval, with robust governance and compensation disclosures.MRMD
Proxy filing23 Apr 2026 - Q2 revenue up 11% to $40.4M; margin pressure persists but 2024 growth targets reaffirmed.MRMD
Q2 20242 Feb 2026 - Q3 2024 revenue up 4.6% to $40.6M, net loss narrows, and wholesale outperforms.MRMD
Q3 202416 Jan 2026 - Record revenue and wholesale gains offset margin pressure and retail softness in 2024.MRMD
Q4 202424 Dec 2025 - Four directors up for election, auditor approval, and key governance and compensation updates.MRMD
Proxy Filing1 Dec 2025 - Wholesale growth offset retail softness; Q2 revenue expected to rise high single digits QoQ.MRMD
Q1 202526 Nov 2025 - Q2 2025 delivered sequential revenue growth, higher EBITDA, and expanded market presence.MRMD
Q2 202523 Nov 2025